Bayesian survival analysis for early detection of treatment effects in phase 3 clinical trials

Despite appealing characteristics for the clinical trials setting, Bayesian inference methods remain scarcely used, especially in randomized controlled clinical trials (RCT). This is particularly true when dealing with a survival endpoint, likely due to the additional complexities to model specifica...

Descripción completa

Detalles Bibliográficos
Autores principales: Biard, Lucie, Bergeron, Anne, Lévy, Vincent, Chevret, Sylvie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817368/
https://www.ncbi.nlm.nih.gov/pubmed/33511301
http://dx.doi.org/10.1016/j.conctc.2021.100709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817368/
https://www.ncbi.nlm.nih.gov/pubmed/33511301
http://dx.doi.org/10.1016/j.conctc.2021.100709

Ejemplares similares